[Antibiotic susceptibility and T-serotypes of group A hemolytic streptococci, clinically isolated in 1986 and 1987]. 1989

A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga

Determination of T-serotype for a total 245 strains (157 strains in 1986, 88 strains in 1987) of Streptococcus pyogenes (Group A hemolytic streptococci) isolated from clinical specimens (throat swab) of pediatric patients in Fukuoka Prefecture from 1986 until 1987 were performed. The susceptibilities of 9 antibiotics against 241 strains were studied. The most dominant strain was T-12 (57 strains, 36.3%) and followed by T-4 (32 strains, 20.4%) and T-28 (30 strains, 19.1%) in 1986. The total of these three strains was 75.8% of all strains. In 1987, T-4 (41 strains, 46.6%) was the dominant strain instead of T-12 (14 strains, 15.9%). T-28 was isolated only 4 strains (4.5%) in 1987, although it was isolated in 30 stains (19.1%) in 1986. In susceptibility-tests, no strains of 1986 and 1987 was resistant to beta-lactams. Resistant strains (MIC greater than or equal to 25 micrograms/ml) to erythromycin (EM), tetracycline (TC) and chloramphenicol (CP) were 4 (2.6%), 51 (33.3%) and 1 (0.7%), respectively in 1986. In 1987, resistant strains to EM and CP were not detected, to TC were 52 strains (59.1%), so there was an increase of susceptibility to EM and CP. As for relationship between T-serotype and antibiotic resistance, only one strain (T-12) showed multiple resistance in 1986, however in 1987, multiple resistant strain was not detected. In 1986 and 1987, 31 of 49 only TC resistant strains (63.3%) and 41 of 52 only TC resistant strains (78.8%) were T-4, respectively.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013297 Streptococcus pyogenes A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER. Flesh-Eating Bacteria,Streptococcus Group A,Bacteria, Flesh-Eating
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
August 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
August 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
August 1991, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
June 1982, The Journal of infectious diseases,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
May 1976, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
November 1989, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
August 1984, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
July 1990, Mikrobiyoloji bulteni,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
June 2000, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
A Kawakami, and K Oda, and M Aramaki, and Y Shimada, and S Tomita, and T Koga, and Y Sakata, and T Nishiyama, and K Ishimoto, and K Tominaga
August 1970, Klinische Wochenschrift,
Copied contents to your clipboard!